Patent · US Active

Ophthalmic compositions containing alcaftadine

US10617695B2 · kind B2 · utility

0Cited by

5References

20Claims

0Family size

Assignee

Vistakon Pharmaceuticals, LLC · US

Inventors

Avner Ingerman · Scarsdale, US
Frans Eduard Janssens · Bonheiden, BE
Anton Megens · Beerse, BE
Mark B. Abelson · Andover, US

Key dates

Filing date	Sep 16, 2016
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Sep 16, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof containing alcaftadine or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.